These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34626587)

  • 1. FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy.
    Xu X; Zhang L; Hua F; Zhang C; Zhang C; Mi X; Qin N; Wang J; Zhu A; Qin Z; Zhou F
    Exp Cell Res; 2021 Nov; 408(2):112863. PubMed ID: 34626587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway.
    Xu X; Qin Z; Zhang C; Mi X; Zhang C; Zhou F; Wang J; Zhang L; Hua F
    Cell Biol Int; 2023 Jun; 47(6):1126-1135. PubMed ID: 36841942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
    He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 5. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L; Ding M; Chen F; Zhu D; Xie X
    PeerJ; 2023; 11():e14826. PubMed ID: 36815984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3/Caspase-1/GSDMD pyroptosis pathway.
    Jiang S; Zhang H; Li X; Yi B; Huang L; Hu Z; Li A; Du J; Li Y; Zhang W
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105789. PubMed ID: 33259938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
    Kim D; Ban KY; Lee GH; Jun HS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
    Zhang Q; Hu Y; Hu JE; Zhang M
    Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
    Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
    J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.
    Li X; Jiang X; Jiang M; Wang ZF; Zhao T; Cao SM; Li QM
    Acta Diabetol; 2024 Feb; 61(2):225-234. PubMed ID: 37847379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.